🧡 The science of alcohol, simplified. 🌎 Connecting science, health, and community. 💡 Research • 🤝 Education • 🌿 Awareness
Joined October 2025
- Tweets94
- Following33
- Followers111
- Likes109
Alcohol Sciences Research Group retweeted
⚽ We're here, we're there, we're gonna be everywhere! ⚽See us in Denver at @AASLDtweets #TLM26!
Proud of Dr @BlaneyMD highlighting this very important topic 🙌🏻
Dr Hanna Blaney @BlaneyMD outlining medical homes for patients with alcoholic liver disease at the postgrad course #ACG2026 medications for alcohol use disorder result in improved survival @AmCollegeGastro multidisciplinary care is important
Check Out our new Exciting Review 🔥
FIB-4 🙌🏻
Excited to share that our review article on the FIB-4 Index in SLD.
Grateful to my co-authors and mentors.
doi.org/10.1111/apt.71037
@juanpabloarab @BlaneyMD @LuisAntonioDiaz @vinayjaha
@RichSterlingMD @ASRG_Liver @OmarAdnanA
#Hepatology #Gastroenterology #SLD #FIB4
Alcohol Sciences Research Group retweeted
As we mark October as Liver Awareness Month, what do you know about Met-ALD? Listen to our @JuanPabloArab discuss metabolic dysfunction and alcohol-associated liver disease on the "7-minute Hepatology" podcast. bit.ly/4gpDs9h @qldhealth @livertwitter @usceduau
ALT Dr. Juan Pablo Arab
Met-ALD and ALD are way more prevalent than you expect.
Check this Out 🔥🔥🙌🏻
In our @AGA_CGH study of 2,870 people screened for MASH trials, 11% had PEth ≥20 ng/mL—warranting evaluation for possible MetALD or ALD. Better alcohol assessment could improve trial selection and interpretation.
authors.elsevier.com/c/1ntqg…
#MASH #MetALD #ALD
Alcohol Sciences Research Group retweeted
In our @AGA_CGH study of 2,870 people screened for MASH trials, 11% had PEth ≥20 ng/mL—warranting evaluation for possible MetALD or ALD. Better alcohol assessment could improve trial selection and interpretation.
authors.elsevier.com/c/1ntqg…
#MASH #MetALD #ALD
Check this out 🙌🏻
Besides FIB-4, what are the other existing quick lab-based screening tests for LiVER FIBROSIS?
This table summarizes the main ones.
#IMTLD2026
Check this out 🔥🙌🏻
Pleased to share our AGA Clinical Practice Update on #MetALD: 9 best practice advice statements on diagnosis, fibrosis assessment, and management. Addressing metabolic risk and alcohol use together is central to care. @AGA_CGH
authors.elsevier.com/a/1nq5Q…
Alcohol Sciences Research Group retweeted
New Dyslipidemia Guidelines
*Screen at age 9-11
*Re-screen age 19
*LDL goal seems to be <100 for EVERYONE even those with LESS than 10% risk
*KEY KEY KEY: Target is under 55 if you have atherosclerotic disease (Coronary, Carotid, Peripheral, Aortic, Cerebral)
MASSIVE change
Amazing session ❤️
Grateful to @GraceSu15 for visiting us at @VCU_Liver and delivering a great talk on Imaging Data in Liver Disease Phenotyping @saulkarpen @ArunJSanyalVCU @RichSterlingMD @JasmohanBajaj
Alcohol Sciences Research Group retweeted
NEW from VCU team in @Intest_Res: Patients with #IBD prescribed tirzepatide may have lower risk of IV steroid use compared to those taking GLP-1RAs. @ArunJSanyalVCU @juanpabloarab @vinayjaha @tariqraseen #livertwitter
ALT A person is holding a GLP-1 injection pen, which is used for medical purposes. The person is dressed in a white top and jeans, with a visible stomach.
Alcohol Sciences Research Group retweeted
I am honored to receive this recognition from @LiverUSA and thank the mentors, colleagues, and, most of all, the patients who helped me in my research, teaching and clinical practice these past four decades.🙏 #livertwitter @VCU_Liver
As American Liver Foundation celebrates 50 years of advancing liver health, we are proud to honor one of the field's most influential pioneers.
Dr. Arun J. Sanyal has helped transform the global understanding and treatment of MASLD and MASH, driving groundbreaking research that has improved the lives of countless patients and families around the world. As Director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University, his leadership continues to shape the future of liver disease prevention, diagnosis, and care.
In this Golden Anniversary year, we are honored to present Arun J. Sanyal, MD with the 2026 National Legacy Gala Leadership Award on October 28 in New York City.
Join us as we celebrate 50 years of impact and recognize the visionary leaders helping create a future without liver disease. alf.social/gala26
@VCU_Liver
#ALF50 #NationalLegacyGala
Alcohol Sciences Research Group retweeted
The boss @ArunJSanyalVCU presenting at AASLD-ALEH SLD Summit during #ALEH2026
Alcohol Sciences Research Group retweeted
An appreciation post to our 2025–2026 LFN Faculty! 💚🧡
We’re incredibly grateful for your dedication, mentorship, and support in making this a successful year of learning and helping inspire the next generation of hepatologists! 🙌
#AASLD #LiverFellowNetwork
Alcohol Sciences Research Group retweeted
Pleased to share our new Nature Reviews Gastroenterology & Hepatology review, “The dynamic spectrum of steatotic liver disease: the global perspective.” Grateful to be among the authors advancing a more integrated, real-world approach to #MASLD, #MetALD, and #ALD.
nature.com/articles/s41575-0…
Alcohol Sciences Research Group retweeted
Check out our review on MASLD and Women’s Health! I had so much fun writing this and hope you all enjoy reading it!
Metabolic dysfunction-associated steatotic liver disease in women acro... sciencedirect.com/science/ar…
Alcohol Sciences Research Group retweeted
Excited to share our new publication in Addiction on the prognostic impact of prior alcohol use disorder in MASLD.
This is a scenario we see often in clinical practice where patients meeting MASLD criteria also have a remote history of alcohol dependence. In our large database study, 1 in 20 patients with presumed MASLD had a prior AUD diagnosis without receiving any subsequent ALD diagnosis. This group showed significantly higher rates of liver events and mortality.
This may reflect the biological sequelae of past alcohol exposure and/or the high AUD relapse rates that go uncaptured during brief, snapshot clinic assessments.
So whenever we see "MASLD with remote history of AUD", this should be a flag for closer monitoring, not a diagnosis to file away as resolved.
@vinayjaha @LuisAntonioDiaz @juanpabloarab
onlinelibrary.wiley.com/doi/…
Alcohol Sciences Research Group retweeted
How does history of AUD shape outcomes in pts with MASLD?
In our multicenter cohort, prior AUD 🍷 was associated with ⬆️ hazards of cirrhosis, decompensation.
Kudos to @butrosfakhoury for leading this 👏 GI twitter, 👀 out for his application this season!
Published in @SSA_Addiction
onlinelibrary.wiley.com/doi/…
Team @juanpabloarab @LuisAntonioDiaz @KaanthiRama @scopeandglobe @VCU_Liver @ASRG_Liver
@AASLDtweets @EASLedu
Alcohol Sciences Research Group retweeted
So thrilled that this project is coming to fruition.
Today, we held a 🎉🎉 for our new Clinical Research Imaging Center. ✅ out our 📹 of @ArunJSanyalVCU talking about the capabilities and goals for the facility. #livertwitter #imaging youtu.be/lTgdy1K-EHg
ALT A new PET/CT scanner
ALT A group of VCU and VCU Health leaders cutting a green ribbon.
ALT Dr. Arun Sanyal